Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Myeloid 1Sarcoma, Clear Cell 1Recurrence 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Large Granular Lymphocytic 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Congenital Abnormalities 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 23Capecitabine 17Cisplatin 11Oxaliplatin 10Fluorouracil 9Leucovorin 8Irinotecan 7Erlotinib Hydrochloride 6pembrolizumab 5Radiotherapy 5Sorafenib 4Interleukin-12 Subunit p35 3Cholangiopancreatography, Endoscopic Retrograde 3Carboplatin 3regorafenib 2dehydroftorafur 2Watchful Waiting 2Trastuzumab 2Pancreaticoduodenectomy 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Long-Term Synaptic Depression 2Lapatinib 2Filgrastim 2Epirubicin 2Drug Therapy 2Dihematoporphyrin Ether 2Chemotherapy, Adjuvant 2Bevacizumab 2trifluridine tipiracil drug combination 1tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bile Duct Neoplasms × devimistat × Clear all
NCT01766219 2019-05-15

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

Wake Forest University Health Sciences

Phase 1/2 Completed
17 enrolled 15 charts
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡